🇺🇸 FDA
Patent

US 8075920

Administration of cells and cellular extracts for rejuvenation

granted A61KA61K31/7088A61K35/36

Quick answer

US patent 8075920 (Administration of cells and cellular extracts for rejuvenation) held by REGENICS AS expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENICS AS
Grant date
Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/7088, A61K35/36, A61K35/60, A61K38/02